{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:35:36Z","timestamp":1794270936525,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41590-025-02219-2","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T15:02:30Z","timestamp":1753801350000},"page":"1367-1383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-6226","authenticated-orcid":false,"given":"Sharanya K. M.","family":"Wijesinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6359-485X","authenticated-orcid":false,"given":"Sarah S.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6613-2354","authenticated-orcid":false,"given":"Giovanni","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-5526","authenticated-orcid":false,"given":"Marco","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-7306","authenticated-orcid":false,"given":"Lifen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-814X","authenticated-orcid":false,"given":"Carlson","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6585-9532","authenticated-orcid":false,"given":"Kevin","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2018-8747","authenticated-orcid":false,"given":"Leonie","family":"Heyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teisha","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0327-8910","authenticated-orcid":false,"given":"Lewis D.","family":"Newland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-2839","authenticated-orcid":false,"given":"Yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-3957","authenticated-orcid":false,"given":"David","family":"Chisanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-2808","authenticated-orcid":false,"given":"Julian","family":"Swatler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Voulaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Marulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Losurdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo R.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-8946","authenticated-orcid":false,"given":"Fernando","family":"Souza-Fonseca-Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-7211","authenticated-orcid":false,"given":"Nicholas D.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-9468","authenticated-orcid":false,"given":"Thomas","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2205-9057","authenticated-orcid":false,"given":"Daniel T.","family":"Utzschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-7678","authenticated-orcid":false,"given":"Enrico","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-6968","authenticated-orcid":false,"given":"Axel","family":"Kallies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"2219_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip, M. & Schietinger, A. CD8+ T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 22, 209\u2013223 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2219_CR2","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles, J. R., Globig, A. M., Kaech, S. M. & Wherry, E. J. CD8+ T cells in the cancer-immunity cycle. Immunity 56, 2231\u20132253 (2023).","journal-title":"Immunity"},{"key":"2219_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-immunol-082223-044122","volume":"43","author":"L Rausch","year":"2025","unstructured":"Rausch, L. & Kallies, A. Molecular mechanisms governing CD8 T cell differentiation and checkpoint inhibitor response in cancer. Annu Rev. Immunol. 43, 515\u2013543 (2025).","journal-title":"Annu Rev. Immunol."},{"key":"2219_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"2219_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"2219_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ni.3543","volume":"17","author":"YA Leong","year":"2016","unstructured":"Leong, Y. A. et al. CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles. Nat. Immunol. 17, 1187\u20131196 (2016).","journal-title":"Nat. Immunol."},{"key":"2219_CR7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"2219_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2019.11.004","volume":"41","author":"E Lugli","year":"2020","unstructured":"Lugli, E., Galletti, G., Boi, S. K. & Youngblood, B. A. Stem, effector, and hybrid states of memory CD8(+) T cells. Trends Immunol. 41, 17\u201328 (2020).","journal-title":"Trends Immunol."},{"key":"2219_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies, A., Zehn, D. & Utzschneider, D. T. Precursor exhausted T cells: key to successful immunotherapy? Nat. Rev. Immunol. 20, 128\u2013136 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2219_CR10","doi-asserted-by":"crossref","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 e110 (2019).","DOI":"10.1016\/j.immuni.2018.12.021"},{"key":"2219_CR11","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"2219_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"2219_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","volume":"176","author":"M Sade-Feldman","year":"2019","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 176, 404 (2019).","journal-title":"Cell"},{"key":"2219_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","volume":"576","author":"CS Jansen","year":"2019","unstructured":"Jansen, C. S. et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 576, 465\u2013470 (2019).","journal-title":"Nature"},{"key":"2219_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","volume":"597","author":"CS Eberhardt","year":"2021","unstructured":"Eberhardt, C. S. et al. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature 597, 279\u2013284 (2021).","journal-title":"Nature"},{"key":"2219_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41590-021-00979-1","volume":"22","author":"KB Yates","year":"2021","unstructured":"Yates, K. B. et al. Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans. Nat. Immunol. 22, 1020\u20131029 (2021).","journal-title":"Nat. Immunol."},{"key":"2219_CR17","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","volume":"21","author":"DT Utzschneider","year":"2020","unstructured":"Utzschneider, D. T. et al. Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat. Immunol. 21, 1256\u20131266 (2020).","journal-title":"Nat. Immunol."},{"key":"2219_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"2219_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"2219_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","volume":"609","author":"C Tsui","year":"2022","unstructured":"Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature 609, 354\u2013360 (2022).","journal-title":"Nature"},{"key":"2219_CR21","doi-asserted-by":"crossref","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity 51, 1043\u20131058.e1044 (2019).","DOI":"10.1016\/j.immuni.2019.11.002"},{"key":"2219_CR22","doi-asserted-by":"crossref","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042.e1024 (2019).","DOI":"10.1016\/j.immuni.2019.10.009"},{"key":"2219_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21619-0","volume":"12","author":"T Yamauchi","year":"2021","unstructured":"Yamauchi, T. et al. T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nat. Commun. 12, 1402 (2021).","journal-title":"Nat. Commun."},{"key":"2219_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature24993","volume":"552","author":"JJ Milner","year":"2017","unstructured":"Milner, J. J. et al. Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours. Nature 552, 253\u2013257 (2017).","journal-title":"Nature"},{"key":"2219_CR25","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","volume":"20","author":"BV Kumar","year":"2017","unstructured":"Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921\u20132934 (2017).","journal-title":"Cell Rep."},{"key":"2219_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/ni.3589","volume":"17","author":"P Hombrink","year":"2016","unstructured":"Hombrink, P. et al. Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nat. Immunol. 17, 1467\u20131478 (2016).","journal-title":"Nat. Immunol."},{"key":"2219_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"2219_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust, D. & Soerens, A. G. Tissue-resident T cells and other resident leukocytes. Annu. Rev. Immunol. 37, 521\u2013546 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"2219_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-018-0812-9","volume":"565","author":"SL Park","year":"2019","unstructured":"Park, S. L. et al. Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin. Nature 565, 366\u2013371 (2019).","journal-title":"Nature"},{"key":"2219_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"2219_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05072-0","volume":"9","author":"T Duhen","year":"2018","unstructured":"Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018).","journal-title":"Nat. Commun."},{"key":"2219_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccell.2023.01.004","volume":"41","author":"B Virassamy","year":"2023","unstructured":"Virassamy, B. et al. Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer. Cancer Cell 41, 585\u2013601.e588 (2023).","journal-title":"Cancer Cell"},{"key":"2219_CR33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas, P. et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat. Med. 24, 986\u2013993 (2018).","journal-title":"Nat. Med."},{"key":"2219_CR34","doi-asserted-by":"crossref","unstructured":"Edwards, J. et al. CD103+ tumor-resident CD8+ T cells are associated with improved survival in immunotherapy-naive melanoma patients and expand significantly during anti-PD-1 treatment. Clin. Cancer Res. 24, 3036\u20133045 (2018).","DOI":"10.1158\/1078-0432.CCR-17-2257"},{"key":"2219_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccell.2022.04.005","volume":"40","author":"A Jaiswal","year":"2022","unstructured":"Jaiswal, A. et al. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. Cancer Cell 40, 524\u2013544.e525 (2022).","journal-title":"Cancer Cell"},{"key":"2219_CR36","doi-asserted-by":"publisher","first-page":"e002231","DOI":"10.1136\/jitc-2020-002231","volume":"9","author":"R Banchereau","year":"2021","unstructured":"Banchereau, R. et al. Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade. J. Immunother. Cancer 9, e002231 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2219_CR37","doi-asserted-by":"crossref","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","DOI":"10.1126\/sciimmunol.abg7836"},{"key":"2219_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell 38, 685\u2013700.e688 (2020).","journal-title":"Cancer Cell"},{"key":"2219_CR39","doi-asserted-by":"publisher","first-page":"e124507","DOI":"10.1172\/jci.insight.124507","volume":"3","author":"MF Fransen","year":"2018","unstructured":"Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight 3, e124507 (2018).","journal-title":"JCI Insight"},{"key":"2219_CR40","doi-asserted-by":"crossref","unstructured":"Prokhnevska, N. et al. CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity 56, 107\u2013124.e105 (2023).","DOI":"10.1016\/j.immuni.2022.12.002"},{"key":"2219_CR41","doi-asserted-by":"crossref","unstructured":"Schenkel, J. M. et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. Immunity 54, 2338\u20132353.e2336 (2021).","DOI":"10.1016\/j.immuni.2021.08.026"},{"key":"2219_CR42","doi-asserted-by":"crossref","unstructured":"Rahim, M. K. et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 186, 1127\u20131143.e1118 (2023).","DOI":"10.1016\/j.cell.2023.02.021"},{"key":"2219_CR43","doi-asserted-by":"crossref","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185, 4049\u20134066.e4025 (2022).","DOI":"10.1016\/j.cell.2022.09.020"},{"key":"2219_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1126\/science.aad2035","volume":"352","author":"LK Mackay","year":"2016","unstructured":"Mackay, L. K. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459\u2013463 (2016).","journal-title":"Science"},{"key":"2219_CR45","doi-asserted-by":"crossref","unstructured":"Gabriel, S. S. et al. Transforming growth factor-\u03b2-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity 54, 1698\u20131714.e1695 (2021).","DOI":"10.1016\/j.immuni.2021.06.007"},{"key":"2219_CR46","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41590-021-01004-1","volume":"22","author":"SN Christo","year":"2021","unstructured":"Christo, S. N. et al. Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity. Nat. Immunol. 22, 1140\u20131151 (2021).","journal-title":"Nat. Immunol."},{"key":"2219_CR47","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.immuni.2020.04.007","volume":"52","author":"JJ Milner","year":"2020","unstructured":"Milner, J. J. et al. Heterogenous populations of tissue-resident CD8+ T cells are generated in response to infection and malignancy. Immunity 52, 808\u2013824.e807 (2020).","journal-title":"Immunity"},{"key":"2219_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn1945","volume":"10","author":"C Gago da Graca","year":"2025","unstructured":"Gago da Graca, C. et al. Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression. Sci. Immunol. 10, eadn1945 (2025).","journal-title":"Sci. Immunol."},{"key":"2219_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"2219_CR50","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity 50, 1498\u20131512.e1495 (2019).","journal-title":"Immunity"},{"key":"2219_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18570-x","volume":"11","author":"Q Peng","year":"2020","unstructured":"Peng, Q. et al. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nat. Commun. 11, 4835 (2020).","journal-title":"Nat. Commun."},{"key":"2219_CR52","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke, L. et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat. Cancer 2, 794\u2013802 (2021).","journal-title":"Nat. Cancer"},{"key":"2219_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"2219_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307\u2013325 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2219_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature18945","volume":"536","author":"EM Verdegaal","year":"2016","unstructured":"Verdegaal, E. M. et al. Neoantigen landscape dynamics during human melanoma\u2013T cell interactions. Nature 536, 91\u201395 (2016).","journal-title":"Nature"},{"key":"2219_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature10755","volume":"482","author":"H Matsushita","year":"2012","unstructured":"Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400\u2013404 (2012).","journal-title":"Nature"},{"key":"2219_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello, D. V. F. et al. TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538\u2013543 (2018).","journal-title":"Nature"},{"key":"2219_CR58","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"2219_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2836-1","volume":"587","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. TGF-\u03b2 suppresses type 2 immunity to cancer. Nature 587, 115\u2013120 (2020).","journal-title":"Nature"},{"key":"2219_CR60","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41467-020-15404-8","volume":"11","author":"AJ Gunderson","year":"2020","unstructured":"Gunderson, A. J. et al. TGF\u03b2 suppresses CD8+ T cell expression of CXCR3 and tumor trafficking. Nat. Commun. 11, 1749 (2020).","journal-title":"Nat. Commun."},{"key":"2219_CR61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2018.03.025","volume":"48","author":"E Tu","year":"2018","unstructured":"Tu, E. et al. T cell receptor-regulated TGF-\u03b2 type I receptor expression determines T cell quiescence and activation. Immunity 48, 745\u2013759 e746 (2018).","journal-title":"Immunity"},{"key":"2219_CR62","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s43018-023-00566-3","volume":"4","author":"V Wischnewski","year":"2023","unstructured":"Wischnewski, V. et al. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation. Nat. Cancer 4, 908\u2013924 (2023).","journal-title":"Nat. Cancer"},{"key":"2219_CR63","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s42003-021-02595-z","volume":"4","author":"A Losurdo","year":"2021","unstructured":"Losurdo, A. et al. Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer. Commun. Biol. 4, 1117 (2021).","journal-title":"Commun. Biol."},{"key":"2219_CR64","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood.V100.2.560","volume":"100","author":"P Leveen","year":"2002","unstructured":"Leveen, P. et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 100, 560\u2013568 (2002).","journal-title":"Blood"},{"key":"2219_CR65","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.2897","volume":"15","author":"FC Steinke","year":"2014","unstructured":"Steinke, F. C. et al. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4+ T cell fate and interact with Runx3 to silence Cd4 in CD8+ T cells. Nat. Immunol. 15, 646\u2013656 (2014).","journal-title":"Nat. Immunol."},{"key":"2219_CR66","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.4049\/jimmunol.180.7.4742","volume":"180","author":"D Voehringer","year":"2008","unstructured":"Voehringer, D., Liang, H. E. & Locksley, R. M. Homeostasis and effector function of lymphopenia-induced \u201cmemory-like\u201d T cells in constitutively T cell-depleted mice. J. Immunol. 180, 4742\u20134753 (2008).","journal-title":"J. Immunol."},{"key":"2219_CR67","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ni.1649","volume":"9","author":"Y Maekawa","year":"2008","unstructured":"Maekawa, Y. et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9, 1140\u20131147 (2008).","journal-title":"Nat. Immunol."},{"key":"2219_CR68","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.2606","volume":"14","author":"DT Utzschneider","year":"2013","unstructured":"Utzschneider, D. T. et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat. Immunol. 14, 603\u2013610 (2013).","journal-title":"Nat. Immunol."},{"key":"2219_CR69","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"2219_CR70","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2219_CR71","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"2219_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"2219_CR73","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2219_CR74","doi-asserted-by":"publisher","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"2219_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40790-0","volume":"14","author":"S Puccio","year":"2023","unstructured":"Puccio, S. et al. CRUSTY: a versatile web platform for the rapid analysis and visualization of high-dimensional flow cytometry data. Nat. Commun. 14, 5102 (2023).","journal-title":"Nat. Commun."},{"key":"2219_CR76","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi, G. et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J. Clin. Invest. 130, 3137\u20133150 (2020).","journal-title":"J. Clin. Invest."},{"key":"2219_CR77","doi-asserted-by":"publisher","unstructured":"Galletti, G., De Luca, M. & Lugli, E. Data related to human CD8+ Tpex cells with\/without Tgfb experiment. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10589058 (2024).","DOI":"10.5281\/zenodo.10589058"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02219-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:00:30Z","timestamp":1757293230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02219-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02219-2","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K. receives research support from Pfizer. N.D.H. is a founder and shareholder in oNKo-Innate and serves on advisory boards for Bristol Myers Squibb and Syena. T.G. was a scientific advisory board member of oNKo-Innate and received research funding from Merck Healthcare KGaA. E.L. is listed as the inventor on a patent on TSCM cells and received royalties related to that patent, received research funding from Bristol Myers Squibb on a topic unrelated to this paper and reports consulting fees from BD Biosciences, BioLegend, Swarm Oncology, Pfizer, Menarini and Astra Zeneca. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}